24/7 Wall St.
Social Security Retirees Get a New Tax Break in 2025. Here’s How to Plan For It
📊
AI Sentiment
Positive
7/10
- Home
- QTTB
QTTB
Q32 Bio Inc.
as of 12-12-2025 3:43pm EST
$2.94
$0.24
-7.55%
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.
Chart Type:
Time Range:
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 25.1M | IPO Year: | N/A |
| Target Price: | $7.33 | AVG Volume (30 days): | 9.0M |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.45 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.34 - $6.37 | Next Earning Date: | 11-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered QTTB Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 73.77%
73.77%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Q32 Bio Inc. (QTTB)
Kalowski Lee
Sell
CFO and President
QTTB Dec 2, 2025
Avg Cost/Share
$3.46
Shares
9,072
Total Value
$31,395.47
Owned After
39,938
SEC Form 4
Sell
QTTB Dec 2, 2025
Avg Cost/Share
$3.46
Shares
22,506
Total Value
$77,870.76
Owned After
99,000
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Kalowski Lee | QTTB | CFO and President | Dec 2, 2025 | Sell | $3.46 | 9,072 | $31,395.47 | 39,938 | |
| Morrison Jodie Pope | QTTB | CEO | Dec 2, 2025 | Sell | $3.46 | 22,506 | $77,870.76 | 99,000 |
Latest Q32 Bio Inc. News
QTTB Breaking Stock News: Dive into QTTB Ticker-Specific Updates for Smart Investing
Yahoo Finance
Federal Reserve: Expect a 'hawkish cut' today as officials look to slow down on interest rate cuts next year
âž–
AI Sentiment
Neutral
5/10
PR Newswire
One of Havertown's Favorite Holiday Traditions - The 2025 Reindeer Romp will be held December 13
📈
AI Sentiment
Highly Positive
9/10
PR Newswire
Zurich launches first-of-its-kind Builders Risk data center solution
📈
AI Sentiment
Highly Positive
8/10
Compare QTTB vs Leading Stocks
See how QTTB stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "QTTB Q32 Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.